直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
    • AI + Finnegan
    • Appeals, Issues, and Legal Strategy
    • Diligence, Licensing, and Opinions
    • Global IP Enforcement, Litigation, and Trials
    • Patent Office Invalidation Proceedings
    • Prosecution and Portfolio Management
    • Trademark and Brand Management
    • AI, Electronics, and Information Technology
    • Chemicals, Industrials, and Materials
    • Communications
    • Consumer Goods and Services
    • Energy
    • Hospitality, Gaming, and Leisure
    • Life Sciences
    • Transportation and Logistics
  • Experience

Experience

Finnegan successfully represents U.S. pharmaceutical company in an arbitration

Represented a U.S. pharmaceutical company in an arbitration with a former consultant and inventor. The dispute involved issues relating to inventorship and ownership, as well as the determination of royalties due under various agreements. The matter settled shortly before the hearing on favorable terms.

Related Professionals

D. Brian Kacedon
Partner
Washington, DC
+1 202 408 4301
Email

Related Practices

Global IP Enforcement, Litigation, and Trials

Arbitration and Other ADR

Related Industries

Life Sciences

Pharmaceutical

Related Experiences

Arbitration victory for major U.S. pharmaceutical company

An international arbitration tribunal rules for Finnegan client on inventorship and contract interpretation disputes

Assisted on a successful claim for an Arrow declaration on behalf of a major pharmaceutical company*

Represented a pharmaceutical company before German Civil Patent Courts*

Represented U.S. software company in patent infringement and invalidity dispute*

Represented U.S. company in patent infringement and nullity proceedings concerning medical devices*

Represented a company in compulsory license proceedings*

Represented U.S. company in series of nullity and infringement proceedings related to consumer products*

Cumberland Pharmaceuticals v. Mylan

Cumberland Pharmaceuticals Inc.

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP